论文部分内容阅读
耐药结核病是当前结核病控制工作的重点和难点,相比较普通结核病来说耐药结核病病程长、治愈率低、死亡率高、危害性更大。政府对耐药结核病防治专项经费投入不足,开展耐多药控制的实验室条件不能满足耐药肺结核病患者诊断需要,专用技术人员治疗水平和管理能力亟待提高。耐多药结核病防治缺乏相关的法规政策,预防意识薄弱,预防措施尚未完全落实。应对耐多药结核病加强可疑者筛查,及时发现耐多药患者,规范临床诊疗活动,通过规划措施从源头上减少耐药结核病的出现。
Drug-resistant TB is the focus and difficulty of the current TB control work. Compared with the common tuberculosis, the drug-resistant TB has a long course of disease, low cure rate, high mortality rate and more harmfulness. The government has insufficient investment in special funds for the prevention and treatment of drug-resistant tuberculosis and the laboratory conditions for drug-resistant multi-drug control can not meet the diagnostic needs of patients with drug-resistant pulmonary tuberculosis. The treatment level and management capacity of specialized technical personnel need to be improved urgently. The lack of relevant regulations and policies for the prevention and treatment of multidrug-resistant tuberculosis and the weak prevention awareness have not yet been fully implemented. MDR-TB should be strengthened to screen for suspicious persons, detect multidrug-resistant patients in time, standardize clinical diagnosis and treatment activities, and reduce the emergence of drug-resistant TB from the source through planning measures.